CN Patent

CN107468662A — 一种治疗消化不良的药物片剂及其制备方法

Assigned to Individual · Expires 2017-12-15 · 8y expired

What this patent protects

本发明涉及医药技术领域，具体涉及一种治疗消化不良的药物片剂及其制备方法。该片剂包括盐酸阿考替胺、肌醇、蔗糖、羧甲基纤维素钙、月桂醇硫酸镁。所述制备方法将采用粉末压片的方法制备成片剂。本发明制备方法简单，相互协同作用提高盐酸阿考替胺的稳定性能、流动性和溶出度，降低吸湿性，有利于临床药品的安全使用和长期储存。

USPTO Abstract

本发明涉及医药技术领域，具体涉及一种治疗消化不良的药物片剂及其制备方法。该片剂包括盐酸阿考替胺、肌醇、蔗糖、羧甲基纤维素钙、月桂醇硫酸镁。所述制备方法将采用粉末压片的方法制备成片剂。本发明制备方法简单，相互协同作用提高盐酸阿考替胺的稳定性能、流动性和溶出度，降低吸湿性，有利于临床药品的安全使用和长期储存。

Drugs covered by this patent

eltrombopag-olamine (ELTROMBOPAG OLAMINE)

Patent Metadata

Patent number: CN107468662A
Jurisdiction: CN
Classification: —
Expires: 2017-12-15
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.